drugset / Trial / NCT02350985

Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine

NCT02350985

Phase 4 Completed 73 enrolled Haseki Training and Research Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The presented study aims to compare effectivity of propranolol with effectivity of venlafaxine in escalating dose in subjects with vestibular migraine (VM) over a period of 12 weeks. The study population consisted of subjects diagnosed definite VM according to criteria of Bárány Society and Migraine Classification Subcommittee of the International Headache Society (IHS). Effectivity of therapy was measured by Dizziness Handicap Inventory (DHI), number of vertiginous attack of last month and visual analogue scale (VAS) reported dizziness related Quality of Life (QOL). Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) were also used to determine psychiatric improvement played role in response to therapy in venlafaxine treatment arm.

Timeline

Start
2014-01
Primary completion
2014-09
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propranolol Small molecule 160 mg Oral
Comparator Venlafaxine Small molecule 150 mg Oral

Indications